Jentashapir Journal of Health Research

Published by: Kowsar

Study on Anti-Hepatitis B Surface Antibody Titer and Specific Interferon Gamma Response Among Dentists

Manoochehr Makvandi 1 , 2 , * , Mojtaba Rasti 1 , Mohammad Hosein Sarmast 3 , Mehrdad Sadeghi Haj 1 , Nasrin Rastegarvand 1 , Dawood Khalafkhani 1 , Rahil Nahid Samiei 1 , 2 , Abdulnabi Shabani 1 , Mohammad Karimi Babaahmadi 4 , Shahram Jalilian 1 , 2 , Kambiz Ahmadi Angali 5 , Toran Shahani 1 , 2 and Mehran Varnasari 6
Authors Information
1 Research Institute for Infectious Diseases of Digestive System, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2 Virology Department, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3 Department of General Surgery, Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
4 Department of Medical Biotechnology, Tabriz University of Medical Sciences, Tabriz, Iran
5 Department of Biostatistics and Epidemiology, School of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
6 Infectious Department, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Article information
  • Jentashapir Journal of Health Research: February 2017, 8 (1); e37477
  • Published Online: January 24, 2017
  • Article Type: Research Article
  • Received: February 28, 2016
  • Revised: January 10, 2017
  • Accepted: January 15, 2017
  • DOI: 10.5812/jjhr.37477

To Cite: Makvandi M, Rasti M, Sarmast M H, Sadeghi Haj M, Rastegarvand N, et al. Study on Anti-Hepatitis B Surface Antibody Titer and Specific Interferon Gamma Response Among Dentists, Jentashapir J Health Res. 2017 ; 8(1):e37477. doi: 10.5812/jjhr.37477.

Copyright © 2017, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Alanko Blome M, Bjorkman P, Flamholc L, Jacobsson H, Widell A. Vaccination against hepatitis B virus among people who inject drugs - A 20year experience from a Swedish needle exchange program. Vaccine. 2017; 35(1): 84-90[DOI][PubMed]
  • 2. Lin XJ, Lao XM, Shi M, Li SP. Changes of HBV DNA After Chemoembolization for Hepatocellular Carcinoma and the Efficacy of Antiviral Treatment. Dig Dis Sci. 2016; 61(9): 2465-76[DOI][PubMed]
  • 3. Ali A, Nisar M, Idrees M, Ahmad H, Hussain A, Rafique S, et al. Prevalence of HBV infection in suspected population of conflict-affected area of war against terrorism in North Waziristan FATA Pakistan. Infect Genet Evol. 2012; 12(8): 1865-9[DOI][PubMed]
  • 4. Norouzian H, Gholami M, Shakib P, Goudarzi G, Ghobadian Diali H, Rezvani A. Prevalence of HCV Infections and Co-Infection With HBV and HIV and Associated Risk Factors Among Addicts in Drug Treatment Centers, Lorestan Province, Iran. Int J High Risk Behav Addict. 2016; 5(1): 25028[DOI][PubMed]
  • 5. Li X, Kang H, Wang S, Deng Z, Yang T, Jia Y, et al. Knowledge, attitude, and behavior of hepatitis b virus infection among chinese dental interns. Hepat Mon. 2015; 15(5): 25079[DOI]
  • 6. Coppola N, De Pascalis S, Onorato L, Calo F, Sagnelli C, Sagnelli E. Hepatitis B virus and hepatitis C virus infection in healthcare workers. World J Hepatol. 2016; 8(5): 273-81[DOI][PubMed]
  • 7. Dini G, Toletone A, Barberis I, Debarbieri N, Massa E, Paganino C, et al. Persistence of protective anti-HBs antibody levels and anamnestic response to HBV booster vaccination: a cross-sectional study among healthcare students 20 years following the universal immunization campaign in Italy. Hum Vaccin Immunother. 2016; [DOI][PubMed]
  • 8. Borzooy Z, Jazayeri SM, Mirshafiey A, Khamseh A, Mahmoudie MK, Azimzadeh P, et al. Identification of occult hepatitis B virus (HBV) infection and viral antigens in healthcare workers who presented low to moderate levels of anti-HBs after HBV vaccination. Germs. 2015; 5(4): 134-40[DOI][PubMed]
  • 9. Elefsiniotis IS, Vezali E, Kamposioras K, Pantazis KD, Tontorova R, Ketikoglou I, et al. Immunogenicity of recombinant hepatitis B vaccine in treatment-naive and treatment-experienced chronic hepatitis C patients: the effect of pegylated interferon plus ribavirin treatment. World J Gastroenterol. 2006; 12(27): 4420-4[DOI][PubMed]
  • 10. Kaymakoglu S, Demir K, Cakaloglu Y, Tuncer I, Dincer D, Gurel S, et al. Combination therapy with hepatitis B vaccine and interferon alfa in chronic hepatitis B. Am J Gastroenterol. 1999; 94(3): 856-7[DOI][PubMed]
  • 11. Kardar GA, Jeddi-Tehrani M, Shokri F. Diminished Th1 and Th2 cytokine production in healthy adult nonresponders to recombinant hepatitis B vaccine. Scand J Immunol. 2002; 55(3): 311-4[DOI][PubMed]
  • 12. Jafarzadeh A, Shokri F. TH1 and TH2 responses are influenced by HLA antigens in healthy neonates vaccinated with recombinant hepatitis B vaccine. Iran J Allergy Asthma Immunol. 2012; 11(4): 308-15[PubMed]
  • 13. La Fauci V, Riso R, Facciola A, Ceccio C, Lo Giudice D, Calimeri S, et al. Response to anti-HBV vaccine and 10-year follow-up of antibody levels in healthcare workers. Public Health. 2016; 139: 198-202[DOI][PubMed]
  • 14. Joukar F, Mansour-Ghanaei F, Naghipour MR, Asgharnezhad M. Immune Responses to Single-Dose Versus Double-Dose Hepatitis B Vaccines in Healthcare Workers not Responding to the Primary Vaccine Series: A Randomized Clinical Trial. Hepat Mon. 2016; 16(2): 32799[DOI][PubMed]
  • 15. Sarmast Shooshtari MH, Makvandi M, Rasti M, Neisi N, Rastegarvand N, Pouremamali A, et al. Evaluation of hepatitis B surface antibody and specific gamma interferon response in health care workers after vaccination. Jundishapur J Microbiol. 2015; 8(1)[DOI][PubMed]
  • 16. Lu CY, Ni YH, Chiang BL, Chen PJ, Chang MH, Chang LY, et al. Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. J Infect Dis. 2008; 197(10): 1419-26[DOI][PubMed]
  • 17. Bertoletti A, Tan AT, Gehring AJ. HBV-Specific Adaptive Immunity. Viruses. 2009; 1(2): 91-103[DOI][PubMed]
  • 18. Dimitropoulou D, Karakantza M, Theodorou GL, Leonidou L, Assimakopoulos SF, Mouzaki A, et al. Serum cytokine profile in patients with hepatitis B e antigen-negative chronic active hepatitis B and inactive hepatitis B virus carriers. World J Gastrointest Pathophysiol. 2013; 4(1): 24-7[DOI][PubMed]
  • 19. Jafarzadeh A, Bagheri-Jamebozorgi M, Nemati M, Golsaz-Shirazi F, Shokri F. Human Leukocyte Antigens Influence the Antibody Response to Hepatitis B Vaccine. Iran J Allergy Asthma Immunol. 2015; 14(3): 233-45[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments